Evidence map›Paper›PMID 34185706›Full record

ArticleThe Journal of clinical investigation2021

TNFR2/14-3-3ε signaling complex instructs macrophage plasticity in inflammation and autoimmunity.

Wenyu Fu, Wenhuo Hu, Young-Su Yi, Aubryanna Hettinghouse, Guodong Sun, Yufei Bi, Wenjun He, Lei Zhang, Guanmin Gao, Jody Liu and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Wenyu FuDepartment of Orthopedic Surgery, New York University Grossman School of Medicine, New York, New York, USA.
Wenhuo HuHuman Oncology and Pathogenesis Program and Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Young-Su YiDepartment of Orthopedic Surgery, New York University Grossman School of Medicine, New York, New York, USA.
Aubryanna HettinghouseDepartment of Orthopedic Surgery, New York University Grossman School of Medicine, New York, New York, USA.
Guodong SunDepartment of Orthopedic Surgery, New York University Grossman School of Medicine, New York, New York, USA.
Yufei BiDepartment of Orthopedic Surgery, New York University Grossman School of Medicine, New York, New York, USA.
Wenjun HeDepartment of Orthopedic Surgery, New York University Grossman School of Medicine, New York, New York, USA.
Lei ZhangDepartment of Orthopedic Surgery, New York University Grossman School of Medicine, New York, New York, USA.
Guanmin GaoDepartment of Orthopedic Surgery, New York University Grossman School of Medicine, New York, New York, USA.
Jody LiuDepartment of Orthopedic Surgery, New York University Grossman School of Medicine, New York, New York, USA.
Kazuhito Toyo-OkaDepartment of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
Guozhi XiaoDepartment of Biochemistry, School of Medicine, Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, Southern University of Science and Technology, Shenzhen, China.
David B SolitHuman Oncology and Pathogenesis Program and Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Png LokeDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Chuan-Ju LiuDepartment of Orthopedic Surgery, New York University Grossman School of Medicine, New York, New York, USA.
New York University · USMemorial Sloan Kettering Cancer Center · USDrexel University · USSouthern University of Science and Technology · CN

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1R01AR062207 · NIAMS · YALE UNIVERSITY · PI Chuanju Liu · 2012 to 2026
$5.6M
The Role of PGRN Growth Factor in Osteoarthritis. - Renewal - 1 - Revision - 2R01AR061484 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LIU, CHUANJU · 2011 to 2020
$4.8M
Progranulin: A Novel Gene in Gaucher DiseasesR01NS103931 · NINDS · YALE UNIVERSITY · PI Chuanju Liu, Ying Sun · 2017 to 2026
$4.3M
Targeting TNF Receptors to Inhibit Inflammation and to Prompt Bone Regeneration in Type 1 Diabetes - Resubmission - 1R01AR076900 · NIAMS · YALE UNIVERSITY · PI LIU, CHUANJU · 2020 to 2024
$2.0M
Role of 14-3-3epsilon in neurite initiationR01NS096098 · NINDS · DREXEL UNIVERSITY · PI TOYO-OKA, KAZUHITO · 2016 to 2020
$1.7M
NCI NIH HHS P30 CA008748NIAMS NIH HHS R01 AR061484NIAMS NIH HHS R01 AR062207NIAMS NIH HHS R01 AR076900NINDS NIH HHS R01 NS096098NINDS NIH HHS R01 NS103931
6 · The paper itself

Abstract

TNFR1 and TNFR2 have received prominent attention because of their dominance in the pathogenesis of inflammation and autoimmunity. TNFR1 has been extensively studied and primarily mediates inflammation. TNFR2 remains far less studied, although emerging evidence demonstrates that TNFR2 plays an antiinflammatory and immunoregulatory role in various conditions and diseases. Herein, we report that TNFR2 regulates macrophage polarization, a highly dynamic process controlled by largely unidentified intracellular regulators. Using biochemical copurification and mass spectrometry approaches, we isolated the signaling molecule 14-3-3ε as a component of TNFR2 complexes in response to progranulin stimulation in macrophages. In addition, 14-3-3ε was essential for TNFR2 signaling-mediated regulation of macrophage polarization and switch. Both global and myeloid-specific deletion of 14-3-3ε resulted in exacerbated inflammatory arthritis and counteracted the protective effects of progranulin-mediated TNFR2 activation against inflammation and autoimmunity. TNFR2/14-3-3ε signaled through PI3K/Akt/mTOR to restrict NF-κB activation while simultaneously stimulating C/EBPβ activation, thereby instructing macrophage plasticity. Collectively, this study identifies 14-3-3ε as a previously unrecognized vital component of the TNFR2 receptor complex and provides new insights into the TNFR2 signaling, particularly its role in macrophage polarization with therapeutic implications for various inflammatory and autoimmune diseases with activation of the TNFR2/14-3-3ε antiinflammatory pathway.

Indexed as

14-3-3 ProteinsAnimalsArthritis, ExperimentalAutoimmunityHumansInflammationMacrophagesMiceMice, KnockoutMultiprotein ComplexesProgranulinsRAW 264.7 CellsReceptors, Tumor Necrosis Factor, Type IISignal Transduction14-3-3 ProteinsGRN protein, humanGrn protein, mouseMultiprotein ComplexesProgranulinsReceptors, Tumor Necrosis Factor, Type IITNFRSF1B protein, humanTnfrsf1b protein, mouseYWHAE protein, humanYwhae protein, mouseArthritisAutoimmune diseasesAutoimmunityInflammationMacrophages

Identifiers

PMID34185706
PMCPMC8363273
OpenAlexW3174884763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.